Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:Expires on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
user
Sign In
Subscribe
ENBM中文TA
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      US data: First month of shots find no safety issues with Pfizer/BioNTech, Moderna vaccines
      Malaysiakini
      News
      US data: First month of shots find no safety issues with Pfizer/BioNTech, Moderna vaccines

      US data: First month of shots find no safety issues with Pfizer/BioNTech, Moderna vaccines

      ReutersPublished: Feb 20, 2021 5:14 AM | Updated: Feb 20, 2021 5:19 AM

      The two Covid-19 vaccines approved for use in the United States have reassuring safety profiles with no concerning new issues found in data collected from the first month of vaccinations, the US Centers for Disease Control and Prevention (CDC) said on Friday.

      After administration of 13.8 million doses of the Pfizer/ BioNTech and Moderna Inc vaccines to the US population, most reports indicated non-serious side effects of the type that had been expected, such as headaches and fatigue. No deaths have been attributed to the vaccines, the data showed...

      Armed with new data, Pfizer suggest storing vaccine at higher temperatures

      Armed with new data, Pfizer suggest storing vaccine at higher temperatures

      'Immunity one gets after Covid-19 recovery not long-term, cannot replace vaccine'

      'Immunity one gets after Covid-19 recovery not long-term, cannot replace vaccine'

      Researchers urge delay in administering Pfizer vaccine's second dose

      Researchers urge delay in administering Pfizer vaccine's second dose

      Pfizer says South African variant could significantly reduce vaccine protection

      Pfizer says South African variant could significantly reduce vaccine protection

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports4

      Armed with new data, Pfizer suggest storing vaccine at higher temperatures

      20-02-2021

      'Immunity one gets after Covid-19 recovery not long-term, cannot replace vaccine'

      19-02-2021

      Researchers urge delay in administering Pfizer vaccine's second dose

      18-02-2021

      Pfizer says South African variant could significantly reduce vaccine protection

      18-02-2021
      View Comments0

      Comments0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      NOTICE

      Our commenting system is still under development. We have taken note of feedback provided.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      3200 characters remaining

      Pending comments0

      Are you sure you want to delete this comment?

      This action cannot be undone.

      Report this comment

      500 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor